S17 Ep32: Previewing Key Myeloma Presentations to Watch at EHA 2026: With Joshua Richter, MD

In today’s episode, we welcomed Joshua Richter, MD, to preview some of the top multiple myeloma presentations anticipated at the 2026 EHA Congress. Richter is an associate professor of medicine in the Division of Hematology and Medical Oncology at the Tisch Cancer Institute and director of Multiple Myeloma at the Blavatnik Family-Chelsea Medical Center at Mount Sinai in New York, New York.In the exclusive interview, Dr Ricther highlighted some of the key abstracts he’s looking forward to seeing presented at EHA 2026, including primary data from an additional study of a bispecific antibody­–based combination being evaluated in the early-relapse setting and longer-term analyses from pivotal phase 3 studies. Richter also shared the key themes and trends he expects to see during the meeting in Stockholm, Sweden.